GSK4112 [Ligand Id: 2903] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL1961795 (GSK4112, SR6452)
  • Liver X receptor-α/LXR-alpha in Human [ChEMBL: CHEMBL2808] [GtoPdb: 602] [UniProtKB: Q13133]
There should be some charts here, you may need to enable JavaScript!
  • Rev-Erb-α/Nuclear receptor subfamily 1 group D member 1 in Human [ChEMBL: CHEMBL1961783] [GtoPdb: 596] [UniProtKB: P20393]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
Liver X receptor-α/LXR-alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2808] [GtoPdb: 602] [UniProtKB: Q13133]
ChEMBL Binding affinity to LXRalpha (unknown origin) by radioligand displacement assay B 5.3 pIC50 5000 nM IC50 J Med Chem (2013) 56: 4729-4737 [PMID:23656296]
Rev-Erb-α/Nuclear receptor subfamily 1 group D member 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1961783] [GtoPdb: 596] [UniProtKB: P20393]
GtoPdb - - 5.64 pIC50 2300 nM IC50 ACS Chem Biol (2011) 6: 131-4 [PMID:21043485]
ChEMBL Agonist activity at Rev-erbalpha assessed as repression of transcription by luciferase-reporter gene assay F 5.64 pEC50 2300 nM EC50 Bioorg Med Chem Lett (2012) 22: 3739-3742 [PMID:22560469]
ChEMBL Agonist activity at Rev-Erbalpha expressed in HEK293 cells coexpressing BamII promoter assessed as repression of transcription after 24 hrs by dual-Glo luciferase assay F 5.64 pEC50 2300 nM EC50 Bioorg Med Chem Lett (2012) 22: 4413-4417 [PMID:22633688]
ChEMBL Agonist activity at Rev-Erb alpha (unknown origin) by FRET assay B 5.64 pEC50 2300 nM EC50 Bioorg Med Chem Lett (2020) 30: 127395-127395 [PMID:32738989]
ChEMBL Agonist activity at biotinylated REV-ERBalpha (unknown origin) assessed as increase in biotinylated NCOR peptide recruitment after 1 hr by FRET assay B 6.3 pEC50 500 nM EC50 J Med Chem (2013) 56: 4729-4737 [PMID:23656296]
ChEMBL Agonist activity at Rev-erbalpha assessed as NCoR recruitment by FRET assay F 6.4 pEC50 400 nM EC50 Bioorg Med Chem Lett (2012) 22: 3739-3742 [PMID:22560469]
GtoPdb - - 6.4 pEC50 400 nM EC50 ACS Chem Biol (2010) 5: 925-32 [PMID:20677822]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]